← All stocks

ANI PHARMACEUTICALS INC

ANIP Net selling
CIK 0001023024 #2131 in the set updated 17 Sep 2026
Bought (120 mo)
$2.23M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$178.54M
$55.52M on a plan · $15.61M straight out of an exercise
Sold at will
$107.41M
89 of 238 sales
Net
−$176.31M
−$105.18M against sales at will

By person

26 insiders · 264 transactions
28.7×

Nikhil Lalwani holds 28.7 times base salary in stock. $24.08M of shares against $837.41K in salary for 2025.

Salary from the company's own proxy. The shares are what Nikhil Lalwani last reported holding, valued at $71.00, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
$276.50K (2)
$58.70M (60) scheduled
−$58.43M
532,976
2.37%
$37.84M
MERIDIAN VENTURE PARTNERS II LP entity
10% owner
$28.62M (10)
−$28.62M
1,819,259
8.09%
$129.17M
−22.6%
Lalwani Nikhil
PRESIDENT & CEO
$200.00K (1)
$19.96M (11)
−$19.76M
339,089
1.51%
$24.08M
Gassert Chad
SVP - CORP. DEV. & STRATEGY
$275.09K (2)
$15.14M (13) scheduled
−$14.87M
233,406
1.04%
$16.57M
MARSHBANKS TRACY
Director
$12.49M (11)
−$12.49M
361,044
1.61%
$25.63M
−35.5%
CAREY STEPHEN P.
SVP & CFO
$8.41M (12) scheduled
−$8.41M
171,843
0.7640%
$12.20M
PRZYBYL ARTHUR
President and CEO
$7.80M (11)
−$7.80M
190,309
0.8461%
$13.51M
−12.1%
Marken James G.
SVP OPS & PROD DEV
$3.77M (7)
−$3.77M
117,829
0.5239%
$8.37M
+142.2%
Mutz Christopher
HEAD OF RARE DISEASE
$2.86M (11) scheduled
−$2.86M
91,309
0.4060%
$6.48M
Schrepfer Robert W
SVP - NEW BUS DEV & SPEC SALES
$2.70M (8) scheduled
−$2.70M
87,477
0.3889%
$6.21M
+403.8%
Gutwerg Ori
SVP, GENERICS
$2.68M (10)
−$2.68M
75,534
0.3358%
$5.36M
Walsh Patrick D
Director
$707.94K (6)
$3.12M (5)
−$2.42M
38,432
0.1709%
$2.73M
RAYNOR DANIEL
Director
$2.18M (6)
−$2.18M
300,113
1.33%
$21.31M
−10.2%
Thoma Jeanne
Director
$49.82K (1)
$1.99M (3)
−$1.94M
26,762
0.1190%
$1.90M
+1,684%
Pera Antonio R
Director
$126.79K (1)
$1.82M (4)
−$1.69M
27,017
0.1201%
$1.92M
Davis Krista
SVP, CHIEF HR OFFICER
$1.62M (12) scheduled
−$1.62M
51,946
0.2310%
$3.69M
HAUGHEY THOMAS
Director
$497.20K (4)
$1.82M (2)
−$1.33M
38,878
0.1729%
$2.76M
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$911.39K (35) scheduled
−$911.39K
73,924
0.3287%
$5.25M
Leonard Matthew J
Director
$840.72K (2)
−$840.72K
11,221
0.0499%
$796.69K
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
$820.24K (3)
−$820.24K
38,271
0.1702%
$2.72M
+9.6%
TANNENBAUM RENEE P
Director
$273.81K (2)
−$273.81K
29,514
0.1312%
$2.10M
NASH DAVID
Director
$99.36K (1)
+$99.36K
38,561
0.1714%
$2.74M
Brown Robert E. JR
Director
49,021
0.2180%
$3.48M
+384.9%
HOLUBOW FRED
Director
14,811
0.0659%
$1.05M
+25.4%
Penn Thomas A.
Director
14,301
0.0636%
$1.02M
+41.5%
Gosebruch Henry O
Director
6,662
0.0296%
$473.00K
Insider
Date
Role
Action
Shares
Price
Amount
Gassert Chad
21 Mar 2022
SVP - CORP. DEV. & STRATEGY
Buy indirect
5,000
$27.87
$139.34K
Walsh Patrick D
21 Mar 2022
Director
Buy
5,000
$27.76
$138.79K
Lalwani Nikhil
21 Mar 2022
PRESIDENT & CEO
Buy
7,224
$27.69
$200.00K
Gassert Chad
18 Mar 2022
SVP - CORP. DEV. & STRATEGY
Buy indirect
5,000
$27.15
$135.74K
Shanmugam Muthusamy
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Buy indirect
5,000
$27.65
$138.25K
Shanmugam Muthusamy
17 Mar 2022
HEAD OF R&D, COO-NOVITIUM OPS
Buy
5,000
$27.65
$138.25K
Thoma Jeanne
20 Dec 2021
Director
Buy
1,072
$46.47
$49.82K
Pera Antonio R
7 Dec 2021
Director
Buy
3,000
$42.26
$126.79K
HAUGHEY THOMAS
6 Dec 2021
Director
Buy
2,500
$39.38
$98.45K
Walsh Patrick D
15 Mar 2021
Director
Buy
4,000
$32.89
$131.56K
Walsh Patrick D
9 Nov 2020
Director
Buy
5,000
$25.96
$129.80K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
3,000
$30.89
$92.67K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
4,000
$30.98
$123.92K
Walsh Patrick D
10 Aug 2020
CHAIRMAN, INTERIM PRES. & CEO
Buy
3,000
$30.40
$91.20K
HAUGHEY THOMAS
4 Mar 2020
Director
Buy
3,000
$45.05
$135.15K
HAUGHEY THOMAS
3 Mar 2020
Director
Buy
2,000
$45.18
$90.36K
NASH DAVID
24 May 2019
Director
Buy
1,445
$68.76
$99.36K
HAUGHEY THOMAS
15 May 2019
Director
Buy
2,500
$69.30
$173.24K
Showing 250 of 264 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 123
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 16 Nov 2016